Contribution of molecular analyses in diagnosing Marfan syndrome and type I fibrillinopathies: an international study of 1009 probands.

Laurence Faivre; Gwenaëlle Collod-Beroud; Anne Child; Bert Callewaert; Bart Loeys; Christine Binquet; Elodie Gautier; Eloisa Arbustini; Karin Mayer; Mine Arslan-Kirchner; Chantal Stheneur; Anatoli Kiotsekoglou; Paolo Comeglio; Nicola Marziliano; Dorothy Halliday; Christophe Béroud; Claire Bonithon-Kopp; Mireille Claustres; Henri Plauchu; Peter Robinson; Lesley Adès; Julie De Backer; Paul Coucke; Uta Francke; Anne De Paepe; Catherine Boileau; Guillaume Jondeau

doi:10.1136/jmg.2007.056382

Contribution of molecular analyses in diagnosing Marfan syndrome and type I fibrillinopathies: an international study of 1009 probands.

Laurence Faivre ^{1, 2} Gwenaëlle Collod-Beroud ³ Anne Child ⁴ Bert Callewaert ⁵ Bart Loeys ^{5, 6} Christine Binquet ² Elodie Gautier ² Eloisa Arbustini ⁷ Karin Mayer ⁸ Mine Arslan-Kirchner ⁹ Chantal Stheneur ^{10, 11} Anatoli Kiotsekoglou ⁴ Paolo Comeglio ⁴ Nicola Marziliano ⁷ Dorothy Halliday ¹² Christophe Béroud ³ Claire Bonithon-Kopp ² Mireille Claustres ³ Henri Plauchu ¹³ Peter Robinson ¹⁴ Lesley Adès ^{15, 16, 17} Julie De Backer ⁵ Paul Coucke ⁵ Uta Francke ¹⁸ Anne De Paepe ⁵ Catherine Boileau ¹⁹ Guillaume Jondeau ¹¹

1 Centre de génétique - Centre de référence des maladies rares, anomalies du développement et syndromes malformatifs (CHU de Dijon)

2 CIC-EC - Centre d'Investigation Clinique 1432 (Dijon) - Epidemiologie Clinique/Essais Cliniques

3 Laboratoire de génétique des maladies rares. Pathologie moleculaire, etudes fonctionnelles et banque de données génétiques

4 Department of Cardiological Sciences

5 Center for Medical Genetics [Ghent]

6 Institute of Genetic Medicine and the Howard Hughes Medical Institute

7 Centre for Inherited Cardiovacular Diseases

8 Center for Human Genetics and Laboratory Medicine

9 Institut für Humagenetik

10 Service de pédiatrie, urgences enfants

11 Consultation Marfan

12 Department of Biochemistry [Oxford]

13 Service de Génétique

14 Institut für Medizinische Genetik

15 Marfan Research Group

16 Department of Clinical Genetics

17 Discipline of Paediatrics and Child Health

18 Department of Genetics and Pediatrics

19 Service de biochimie, d'hormonologie et de génétique moléculaire

Abstract : BACKGROUND: The diagnosis of Marfan syndrome (MFS) is usually initially based on clinical criteria according to the number of major and minor systems affected following international nosology. The number of FBN1 mutation carriers, at risk of aortic complications who would not be properly diagnosed based only on clinical grounds, is of growing importance owing to the increased availability of molecular screening. The aim of the study was to identify patients who should be considered for FBN1 mutation screening. METHODS: Our international series included 1009 probands with a known FBN1 mutation. Patients were classified as either fulfilling or not fulfilling "clinical" criteria. In patients with unfulfilled "clinical" criteria, we evaluated the percentage of additional patients who became positive for international criteria when the FBN1 mutation was considered. The aortic risk was evaluated and compared in patients fulfilling or not fulfilling the "clinical" international criteria. RESULTS: Diagnosis of MFS was possible on clinical grounds in 79% of the adults, whereas 90% fulfilled the international criteria when including the FBN1 mutation. Corresponding figures for children were 56% and 85%, respectively. Aortic dilatation occurred later in adults with unfulfilled "clinical criteria" when compared to the Marfan syndrome group (44% vs 73% at 40 years, p<0.001), but the lifelong risk for ascending aortic dissection or surgery was not significantly different in both groups. CONCLUSIONS: Because of its implications for aortic follow-up, FBN1 molecular analysis is recommended in newly suspected MFS when two systems are involved with at least one major system affected. This is of utmost importance in patients without aortic dilatation and in children.

Type de document :

Article dans une revue

Journal of Medical Genetics, BMJ Publishing Group, 2008, 45 (6), pp.384-90. 〈10.1136/jmg.2007.056382〉

Domaine :

Sciences du Vivant [q-bio] / Génétique

Liste complète des métadonnées

Littérature citée [26 références] Voir Masquer Télécharger

http://www.hal.inserm.fr/inserm-00343946
Contributeur : Gwenaëlle Collod-Beroud <>
Soumis le : mercredi 20 décembre 2017 - 19:03:20
Dernière modification le : vendredi 8 juin 2018 - 14:50:10

2008-JMedGenet H...

Fichiers produits par l'(les) auteur(s)

Contribution of molecular analyses in diagnosing Marfan syndrome and type I fibrillinopathies: an international study of 1009 probands.

Fichier

Identifiants

Collections

Citation

Exporter

Métriques

335

45

Contact

Contribution of molecular analyses in diagnosing Marfan syndrome and type I fibrillinopathies: an international study of 1009 probands.

Fichier

Identifiants

Collections

Citation

Exporter

Partager

Métriques

335

45

Contact